Wednesday, December 20, 2006

Zyprexa protective order update

We posted on Monday about the two cover stories in the New York Times about Zyprexa that were based on internal Eli Lilly documents that might have been disclosed in violation of a protective order. We withheld judgment on whether the documents had been disclosed lawfully or not, because we just don't know; we are outsiders to the Zyprexa litigation.

The court now appears to have sided with Lilly. On Monday, Judge Cogan (in Judge Weinstein's absence) entered an "Order for Mandatory Injunction" enjoining the lawyer who gave the documents to the Times from further disseminating the documents and requiring him to return the documents and to preserve certain information relating to how he obtained and distributed the documents.

Here's a link to the order.

If we learn more, you'll learn more.

1 comment:

Danny Haszard said...

Zyprexa Zooming

Eli Lilly top drug Zyprexa had it's zenith or now zonked? Leaked documents don't convey the 'whole picture' but what is compelling is that zyprexa is the 7th some say 5th largest drug sell in the world and Eli Lilly's #1 by their own admission.

This is for a drug that won't get you "high" cost $2.50 a pill and only indicated for less than 1% of the population. Hello!Somebody in Lilly land is pushing zyprexa hard-Daniel Haszard (former 4 year zyprexa zonker who got diabetes)